• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018 - Product Image

Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018

  • ID: 2245047
  • September 2012
  • Region: Finland
  • 69 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer HealthCare AG
  • F. Hoffmann-La Roche Ltd.
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • Terumo Corporation
  • MORE

Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018

Summary

Global Markets Direct’s new report, ”Finland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018”, provides key market data on the Finland Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average READ MORE >

FEATURED COMPANIES

  • Abbott Laboratories
  • Bayer HealthCare AG
  • F. Hoffmann-La Roche Ltd.
  • Medtronic, Inc.
  • Novo Nordisk A/S
  • Terumo Corporation
  • MORE

1
1 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What is This Report About? 7
3 Diabetes Care Devices In Finland 8
3.1 Diabetes Care Devices, Finland, Overall Revenue ($m) , USD Constant, 2004-2018 8
3.2 Diabetes Care Devices, Finland, Company Share (2010-2011) 14
4 Glucose Monitoring In Finland 16
4.1 Glucose Monitoring Overall Revenue, (2004-2018) 16
4.1.1 Blood Glucose Meters, Revenue (2004-2018) 20
4.2 Glucose Monitoring Overall Volume (2004-2018) 24
4.2.1 Blood Glucose Meters, Volume (2004-2018) 28
4.3 Glucose Monitoring Average Price (2004-2018) 30
4.4 Glucose Monitoring Distribution Share (2010-2011) 31
4.5 Glucose Monitoring, Finland, Company Share (2010-2011) 32
5 Insulin Delivery In Finland 34
5.1 Insulin Delivery Overall Revenue, (2004-2018) 34
5.1.1 Insulin Pens, Revenue (2004-2018) 38
5.1.2 Insulin Pumps, Revenue (2004-2018) 42
5.2 Insulin Delivery Overall Volume (2004-2018) 44
5.2.1 Insulin Pens, Volume (2004-2018) 48
5.2.2 Insulin Pumps, Volume (2004-2018) 52
5.3 Insulin Delivery Average Price (2004-2018) 54
5.4 Insulin Delivery Distribution Share (2010-2011) 55
5.5 Insulin Delivery, Finland, Company Share (2010-2011) 56
6 Overview of Key Companies in Finland Diabetes Care Devices Market 58
6.1 F. Hoffmann-La Roche Ltd. 58
6.1.1 Company Overview 58
6.2 LifeScan, Inc. 58
6.2.1 Company Overview 58
6.3 Eli Lilly and Company 59
6.3.1 Company Overview 59
6.4 Sanofi 59
6.4.1 Company Overview 59
6.5 Bayer HealthCare AG 60
6.5.1 Company Overview 60
6.6 Medtronic, Inc. 60
6.6.1 Company Overview 60
6.7 Abbott Laboratories 61
6.7.1 Company Overview 61
6.8 Novo Nordisk A/S 61
6.8.1 Company Overview 61
6.9 Becton, Dickinson and Company 62
6.9.1 Company Overview 62
6.10 Terumo Corporation 62
6.10.1 Company Overview 62
6.11 Animas Corporation 63
6.11.1 Company Overview 63
6.12 Ypsomed Holding AG 63
6.12.1 Company Overview 63
6.13 Nipro Corporation 63
6.13.1 Company Overview 63
7 Appendix 64
7.1 Global Markets Direct Research Methodology 64
7.2 Definitions of Markets Covered in the Report 65
7.2.1 Diabetes Care Devices 65
7.3 Secondary Research 67
7.4 Primary Research 67
7.5 Models 68
7.6 Forecasts 68
7.7 Expert Panel Validation 68
7.8 Currency Conversion 69
7.9 Contact Us 69
7.10 Disclaimer 69

1.1 List of Tables
Table 1: Diabetes Care Devices, Finland, Overall Revenue ($m) , USD Constant, 2004-2018 9
Table 2: Diabetes Care Devices, Finland, Overall Revenue ($m), USD Constant, Historic, 2004-2011 11
Table 3: Diabetes Care Devices, Finland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 13
Table 4: Diabetes Care Devices, Finland, Company Share by Revenue ($m), USD Constant, 2010-2011 15
Table 5: Glucose Monitoring, Finland, Revenue ($m) USD Constant, by Segment , Historic, 2004-2011 17
Table 6: Glucose Monitoring, Finland, Revenue ($m) USD Constant, by Segment , Forecast, 2011-2018 19
Table 7: Blood Glucose Meters, Finland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 21
Table 8: Blood Glucose Meters, Finland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 23
Table 9: Glucose Monitoring, Finland, Volume (Units) by Segment, Historic, 2004-2011 25
Table 10: Glucose Monitoring, Finland, Volume (Units) by Segment, Forecast, 2011-2018 27
Table 11: Blood Glucose Meters, Finland, Volume (Units) by Sub-Segment, Historic, 2004-2011 28
Table 12: Blood Glucose Meters, Finland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 29
Table 13: Glucose Monitoring, Finland, Average Price ($), Historic, 2004-2011 30
Table 14: Glucose Monitoring, Finland, Average Price ($), Forecast, 2011-2018 30
Table 15: Glucose Monitoring, Finland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 31
Table 16: Glucose Monitoring, Finland, Company Share by Revenue ($m), USD Constant, 2010-2011 33
Table 17: Insulin Delivery, Finland, Revenue ($m) USD Constant, by Segment , Historic, 2004-2011 35
Table 18: Insulin Delivery, Finland, Revenue ($m) USD Constant, by Segment , Forecast, 2011-2018 37
Table 19: Insulin Pens, Finland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 39
Table 20: Insulin Pens, Finland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 41
Table 21: Insulin Pumps (Traditional Insulin Pumps), Finland, Revenue ($m) USD Constant, Historic, 2004-2011 42
Table 22: Insulin Pumps (Traditional Insulin Pumps), Finland, Revenue ($m) USD Constant, Forecast, 2011-2018 43
Table 23: Insulin Delivery, Finland, Volume (Units) by Segment, Historic, 2004-2011 45
Table 24: Insulin Delivery, Finland, Volume (Units) by Segment, Forecast, 2011-2018 47
Table 25: Insulin Pens, Finland, Volume (Units) by Sub-Segment, Historic, 2004-2011 49
Table 26: Insulin Pens, Finland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 51
Table 27: Insulin Pumps (Traditional Insulin Pumps), Finland, Volume (Units), Historic, 2004-2011 52
Table 28: Insulin Pumps (Traditional Insulin Pumps), Finland, Volume (Units), Forecast, 2011-2018 53
Table 29: Insulin Delivery, Finland, Average Price ($), Historic, 2004-2011 54
Table 30: Insulin Delivery, Finland, Average Price ($), Forecast, 2011-2018 54
Table 31: Insulin Delivery, Finland, Distribution Share by Revenue ($m), USD Constant, 2010-2011 55
Table 32: Insulin Delivery, Finland, Company Share by Revenue ($m), USD Constant, 2010-2011 57

1.2 List of Figures
Figure 1: Diabetes Care Devices, Finland, Overall Revenue ($m) , USD Constant, 2004-2018 8
Figure 2: Diabetes Care Devices, Finland, Overall Revenue ($m), USD Constant, Historic, 2004-2011 10
Figure 3: Diabetes Care Devices, Finland, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 12
Figure 4: Diabetes Care Devices, Finland, Company Share (%), 2011 14
Figure 5: Glucose Monitoring, Finland, Revenue ($m) USD Constant, by Segment , Historic, 2004-2011 16
Figure 6: Glucose Monitoring, Finland, Revenue ($m) USD Constant, by Segment , Forecast, 2011-2018 18
Figure 7: Blood Glucose Meters, Finland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 20
Figure 8: Blood Glucose Meters, Finland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 22
Figure 9: Glucose Monitoring, Finland, Volume (Units) by Segment, Historic, 2004-2011 24
Figure 10: Glucose Monitoring, Finland, Volume (Units) by Segment, Forecast, 2011-2018 26
Figure 11: Blood Glucose Meters, Finland, Volume (Units) by Sub-Segment, Historic, 2004-2011 28
Figure 12: Blood Glucose Meters, Finland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 29
Figure 13: Glucose Monitoring, Finland, Company Share (%), 2011 32
Figure 14: Insulin Delivery, Finland, Revenue ($m) USD Constant, by Segment , Historic, 2004-2011 34
Figure 15: Insulin Delivery, Finland, Revenue ($m) USD Constant, by Segment , Forecast, 2011-2018 36
Figure 16: Insulin Pens, Finland, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 38
Figure 17: Insulin Pens, Finland, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 40
Figure 18: Insulin Pumps (Traditional Insulin Pumps), Finland, Revenue ($m) USD Constant, Historic, 2004-2011 42
Figure 19: Insulin Pumps (Traditional Insulin Pumps), Finland, Revenue ($m) USD Constant, Forecast, 2011-2018 43
Figure 20: Insulin Delivery, Finland, Volume (Units) by Segment, Historic, 2004-2011 44
Figure 21: Insulin Delivery, Finland, Volume (Units) by Segment, Forecast, 2011-2018 46
Figure 22: Insulin Pens, Finland, Volume (Units) by Sub-Segment, Historic, 2004-2011 48
Figure 23: Insulin Pens, Finland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 50
Figure 24: Insulin Pumps (Traditional Insulin Pumps), Finland, Volume (Units), Historic, 2004-2011 52
Figure 25: Insulin Pumps (Traditional Insulin Pumps), Finland, Volume (Units), Forecast, 2011-2018 53
Figure 26: Insulin Delivery, Finland, Company Share (%), 2011 56
Figure 27: Our Methodology 64

F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Eli Lilly and Company
Sanofi
Bayer HealthCare AG
Medtronic, Inc.
Abbott Laboratories
Novo Nordisk A/S
Becton, Dickinson and Company
Terumo Corporation
Animas Corporation
Ypsomed Holding AG
Nipro Corporation

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos